Abstract
In 1,009 patients with atrial fibrillation and congestive heart failure, the 2-year mortality rate was 31% in patients treated with rate control (n = 505) versus 29% in patients treated with rhythm control (n = 504). After adjusting for differences in baseline characteristics and medications, no significant difference in mortality was found between the 2 groups.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Anti-Arrhythmia Agents / therapeutic use*
-
Anticoagulants / therapeutic use
-
Atrial Fibrillation / complications*
-
Atrial Fibrillation / mortality
-
Atrial Fibrillation / prevention & control*
-
Calcium Channel Blockers / therapeutic use
-
Chi-Square Distribution
-
Digoxin / therapeutic use
-
Female
-
Heart Failure / complications*
-
Heart Failure / mortality
-
Humans
-
Male
-
Proportional Hazards Models
-
Statistics, Nonparametric
-
Treatment Outcome
-
Warfarin / therapeutic use
Substances
-
Adrenergic beta-Antagonists
-
Anti-Arrhythmia Agents
-
Anticoagulants
-
Calcium Channel Blockers
-
Warfarin
-
Digoxin